Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015)

International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study

(2015) D. S. Fuller et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Erythropoiesis-Stimulating Agent Use Among Non–Dialysis-Dependent CKD Patients Before and After the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Using a Large US Health Plan Database

(2014) Mae Thamer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD

(2013) Alan S. Kliger et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

How important is transfusion avoidance in 2013?

(2013) I. C. Macdougall et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effect of Red Cell Transfusions on Future Kidney Transplantation

(2012) G. T. Obrador et al.   Clinical Journal of the American Society of Nephrology

Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009

(2010) D. Regidor et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Resolved: Targeting a Higher Hemoglobin Is Associated with Greater Risk in Patients with CKD Anemia: Pro

(2009) A. K. Singh et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Predictors of ESA Use in the Non-Dialysis Chronic Kidney Disease Population with Anemia

(2009) Allan J. Collins et al.   NEPHRON CLINICAL PRACTICE

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

(2009) Marc A. Pfeffer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use and prescribing patterns for erythropoiesis-stimulating agents in inpatient and outpatient hospital settings

(2008) J. Siegel et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY